Columvi Europska Unija - hrvatski - EMA (European Medicines Agency)

columvi

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

Talvey Europska Unija - hrvatski - EMA (European Medicines Agency)

talvey

janssen-cilag international n.v. - talquetamab - multipli mijelom - antineoplastična sredstva - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

KOŽNI STAPLERI Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

koŽni stapleri

sanyko d.o.o., zagreb - jednokratni sterilni proizvodi za spajanje kože